Biopharmaceutical Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Biopharmaceutical Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Report Format: PDF+Excel | Report ID: SR112023A724
Buy Now

Market Overview:

The global biopharmaceutical manufacturing market size reached US$ 371.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 690.7 Billion by 2028, exhibiting a growth rate (CAGR) of 10.6% during 2023-2028.

The manufacturing of biopharmaceuticals (biopharma) is characterized by a highly complex research and development (R&D) setting, which includes the use of technologies that are harnessed by new scientific advances. The production process of biopharmaceuticals supports a wide range of production-related, highly specialized jobs. Some of these employments include packaging and filling machine operators and tenders, blending and mixing machine setters, and testers, inspectors, samplers, sorters, and chemical equipment operators. Different methods can be deployed for the production of biopharmaceuticals, which include continuous and follow-on manufacturing systems. In the continuous system, raw materials are fed continuously from one end into the process and the finished product is extracted from the other end. On the other hand, the follow-on product development mostly includes the adoption of both current and legacy bioprocessing technologies to obtain a cost-effective procedure to make drugs.

With the emergence of the industrial revolution 4.0, biopharma manufacturers have been increasingly using a digitized paradigm that involves machines to collect, process and produce data, then communicate it with other machines through the Industrial Internet of Things (IIoT). These next-generation technologies have helped industry players to increase process understanding with the provision of more data with advanced modeling techniques and analytics. Besides this, expansion in the biopharma industry has led to the emerging trend of outsourcing due to high costs, and lack of expertise in in-house manufacturing. As a result, contract manufacturing organizations (CMOs) are investing heavily to expand their existing capabilities and capacities. Most of these firms are based across developed regions. However, the advent of advanced manufacturing methods and technologies in emerging economies, like India and China, has led to a significant shift in the market. Also, the industry currently accounts for a sophisticated, specialized and highly regulated field with outsized economic contributions across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biopharmaceutical manufacturing market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on cell culture and class.

Breakup by Cell Culture:

  • Mammalian
  • Microbial

At present, mammalian cell culture is the largest segment in the market.

Breakup by Class:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Interferon
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Erythropoietin
  • Recombinant Human Insulin
  • Vaccines
  • Human Growth Hormones (HGH)

Amongst the above-mentioned categories, monoclonal antibodies dominate the market.

Regional Insights:

  • North America
  • Europe
  • Asia

Currently, North America is the biggest market, accounting for the majority of the total market share.

Competitive Landscape:

The report has also analyzed the competitive landscape of the market, with some of the key players being F. Hoffmann-La Roche Ltd, Amgen Inc., Novo Nordisk A/S, AbbVie Inc., Groupe Sanofi, Johnson & Johnson Services, Inc., Pfizer Inc., Merck & Co., Inc., Eli Lilly and Company, and Biogen Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units Kilo Liters
Cell Cultures Covered Mammalian, Microbial
Classes Covered Monoclonal Antibodies, Recombinant Proteins, Interferon, Granulocyte Colony-Stimulating Factor (G-CSF), Erythropoietin, Recombinant Human Insulin, Vaccines, Human Growth Hormones (HGH)
Region Covered North America, Europe, Asia
Companies Covered F. Hoffmann-La Roche Ltd, Amgen Inc., Novo Nordisk A/S, AbbVie Inc., Groupe Sanofi, Johnson & Johnson Services, Inc., Pfizer Inc., Merck & Co., Inc., Eli Lilly and Company, and Biogen Inc
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the global biopharmaceutical industry performed so far and how will it perform in the coming years?
  • What are the current and historical manufacturing capacity trends in the biopharmaceutical manufacturing industry?
  • What has been the impact of COVID-19 on the global biopharmaceutical industry?
  • What are the key regional markets in the industry?
  • What is the breakup of the market based on the class?
  • What is the breakup of the market based on the cell culture?
  • What is the structure of the industry and who are the key players?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Biopharmaceutical Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Select License Type

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More